To tackle one of the most urgent public health crises facing the world today – antimicrobial resistance (AMR) – universal health coverage (UHC) must be realized. It’s time to take action by ensuring that everyone has access to safe, effective, quality-assured medicines.
This month marks the one-year anniversary of our Medicines We Can Trust campaign. To commemorate our first campaign milestone, below you’ll see a snapshot of progress over the last year, including a social media toolkit that we hope you’ll share on your channels.
This Thursday (25 April) is World Malaria Day and we hope you’ll join us in calling for #MedsWeCanTrust. If you or your organization would be willing to share social media content on this topic, please see our #WorldMalariaDay social media toolkit for suggested language and graphics.
Every person has the right to expect that when they use a medical product, whether medicine, vaccine or diagnostic kit, it works. But too often, that is not the case. Substandard medical products result from errors, negligence or poor practice in manufacturing, transportation and/or storage.
During this month’s United Nations General Assembly (UNGA), countries will host the first-ever High-Level Meeting on Universal Health Coverage (UHC), where they will issue a political declaration to accelerate progress toward health for all by 2030.
In response to the growing AMR crisis, the UN Interagency Coordination Group on Antimicrobial Resistance (IACG) – which was created following the UN High-Level Meeting on AMR in 2016 – released its seminal report with recommendations on how to curb the spread of AMR.
Over the past few weeks since the World Health Assembly, we’ve seen quality integrated into seminal reports and WHO action plans on antimicrobial resistance (AMR), drug procurement and universal health coverage (UHC). We’re excited to see links made across these issues.